BICO and Nanochon to Develop 3D Printed Joint Restoration Implant 

BICO and Nanochon to Develop 3D Printed Joint Restoration Implant 

by Medical

Bioconvergence company BICO is partnering with Nanochon, a startup developing regenerative joint replacements. Under the terms of the deal, Nanochon will purchase $1.5 million worth of products and services from BICO’s SCIENION to develop 3D printed regenerative joint implants. Nanochon’s novel joint implant technology promises to deliver faster and more successful recoveries for patients while reducing costs to health providers, payers, and patients.

Eardrum-restoring PhonoGraft enters commercial development

Eardrum-restoring PhonoGraft enters commercial development

by Medical

The PhonoGraft biomimetic hearing-restoration technology, advanced through a six-year effort by a multidisciplinary research team at the Wyss Institute for Biologically Inspired Engineering, Harvard’s John A. Paulson School of Engineering and Applied Sciences (SEAS), and Massachusetts Eye and Ear (MEE)/Mass General Brigham (MGB), has now entered commercial development. If successful, it could mitigate pain, drainage, and hearing loss associated with eardrum perforations that affect millions of individuals worldwide.

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

by Medical

FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.

INKplant Projects Targets Use of AM in Regenerative Medicine to Address Aging of European Population

INKplant Projects Targets Use of AM in Regenerative Medicine to Address Aging of European Population

by Medical

Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on health care. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent and risk-grouped patients can become. Therefore, science and technology must work together to ensure that living longer can be synonymous with living well. INKplant, a project funded by the European Union H2020, was conceived to face this challenge and democratize its new solutions.